https://www.selleckchem.com/pr....oducts/Fluvastatin-S
The concentration of natalizumab in breast milk and serum of infants was low; B cells normal in infants breastfed under anti-CD20. CONCLUSION More data on the effect of Mab exposure during pregnancy are needed. Otherwise, our data suggest that treatment with natalizumab, ocrelizumab, or rituximab during lactation might be safe for breastfed infants. Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.Myalgic encephalomyelitis/chronic fatigue syndrome
Like
Comment
Share
